NDC 50090-5805 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC50090-5805

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
A-S Medication Solutions
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA207276
Marketed since
October 25, 2017
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (1)

Package NDCDescriptionSince
50090-5805-030 TABLET in 1 BOTTLE (50090-5805-0)Oct 15, 2021

Other Buprenorphine products